Approval · Notice of Compliance 5471 · 1994
COVERSYL: Notice of Compliance 5471
Issued September 21, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5471
- Date
- September 21, 1994
- Company
- Servier Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
Medicinal ingredients
- PERINDOPRIL ERBUMINE 2 MG per TAB
- PERINDOPRIL ERBUMINE 4 MG per TAB